Solicitation of Nominations for Appointment to the Interagency Committee on Smoking and Health (ICSH), 53155-53156 [2019-21582]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 193 / Friday, October 4, 2019 / Notices
related activities occur in accordance
with applicable privacy laws and
policies.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
Centers for Disease Control and
Prevention
[FR Doc. 2019–21629 Filed 10–3–19; 8:45 am]
Mine Safety and Health Research
Advisory Committee (MSHRAC)
BILLING CODE 4163–18–P
AGENCY:
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Mine Safety and Health Research
Advisory Committee (MSHRAC). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates approximately 75
people. If you wish to attend in person
or by phone, please contact Marie
Chovanec by email at MChovanec@
cdc.gov or by phone at 412–386–5302 at
least 5 business days in advance of the
meeting.
DATES: The meeting will be held on
November 13, 2019, 8:45 a.m.–4:30
p.m., EDT and on November 14, 2019,
8:15 a.m.–12:00 p.m. EDT.
ADDRESSES: Atlanta Marriott Northeast/
Emory Area, 2000 Century Boulevard
NE, Atlanta, GA 30345 United States.
FOR FURTHER INFORMATION CONTACT:
Jeffrey H. Welsh, Designated Federal
Officer, MSHRAC, NIOSH, CDC, 626
Cochrans Mill Road, Pittsburgh, PA
15236, telephone 412–386–4040; email
juw5@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This committee is charged
with providing advice to the Secretary,
Department of Health and Human
Services; the Director, CDC; and the
Director, NIOSH, on priorities in mine
safety and health research, including
grants and contracts for such research,
30 U.S.C. 812(b)(2), Section 102(b)(2).
Matters To Be Considered: The agenda
will include discussions on mining
safety and health research projects and
outcomes, including updates from two
MSHRAC Workgroups, the Health
Advisory in the Mining Program
(HAMP) workgroup and the Metal
Mining Automation and Advanced
Technologies (MMAAT) workgroup,
external review of the NIOSH Mining
program recommendations, NIOSH
Mining Program strategic plan update,
update on acquiring a replacement for
the Lake Lynn Experimental Mine,
proximity detection research, corrosion
research, update on miner health data
sources and analyses, update on fatigue
research, update on EOS–RCS
monitoring method, and canopy air
SUMMARY:
Centers for Disease Control and
Prevention
Delegation of Authority
Notice is hereby given that I have
delegated to the Chief Operating Officer,
Centers for Disease Control and
Prevention (CDC), without the authority
to redelegate, the authority vested in the
Secretary of HHS by section 212(1) of
the Department of Defense and Labor,
Health and Human Services, and
Education Appropriations Act, 2019 and
Continuing Appropriations Act, 2019
(FY 19 HHS Appropriations Act) Public
Law No. 115–245, division B, title II, or
substantially similar authorities vested
in the Secretary in the future by
Congress, in order to carry out
international health activities to
respond to the current Ebola outbreak.
The authority under section 212(1) is
immediately revoked in the event that
any subsequent fiscal year HHS
appropriations act does not contain the
provision currently in section 212(1) or
substantially similar authority.
The Chief Operating Officer, CDC,
shall consult with the Secretary of State
and relevant Chief of Mission to ensure
that this authority is exercised in a
manner consistent with section 207 of
the Foreign Service Act of 1980 and
other applicable statutes administered
by the Department of State.
This delegation became effective on
September 26, 2019 and is valid until
September 18, 2020.
Robert R. Redfield,
Director, Centers for Disease Control and
Prevention.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2019–21580 Filed 10–3–19; 8:45 am]
BILLING CODE 4163–18–P
VerDate Sep<11>2014
16:49 Oct 03, 2019
Jkt 250001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
53155
curtain research. The meeting will also
include updates from the NIOSH
Associate Director for Mining, the
Spokane Mining Research Division, and
the Pittsburgh Mining Research
Division. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–21581 Filed 10–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Interagency
Committee on Smoking and Health
(ICSH)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ICSH. The ICSH consists of 5 experts in
fields that represent private entities
involved in informing the public about
the health effects of smoking.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of the
health effects of smoking. Additionally,
desirable qualifications include: (1)
Knowledge of emerging tobacco control
policies and experience in analyzing,
evaluating, and interpreting Federal,
State and/or local health or regulatory
policy; and/or (2) familiarity and
expertise in developing or contributing
to the development of policies and/or
programs for reducing health disparities
in tobacco use in the United States; and/
or (3) knowledge of the intersection of
behavioral health conditions (mental
and/or substance use disorders) and
tobacco use/tobacco control. Federal
employees will not be considered for
membership. Members may be invited
SUMMARY:
E:\FR\FM\04OCN1.SGM
04OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
53156
Federal Register / Vol. 84, No. 193 / Friday, October 4, 2019 / Notices
to serve for four-year terms. Selection of
members is based on candidates’
qualifications to contribute to the
accomplishment of ICSH objectives
https://www.cdc.gov/tobacco/about/
icsh/index.htm.
DATES: Nominations for membership on
the ICSH must be received no later than
October 31, 2019. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Monica Swann, Office on
Smoking and Health, National Center
for Chronic Disease Prevention and
Health Promotion (NCCDPHP), CDC,
395 E Street SW, Room 9167,
Washington, DC 20024, emailed
(recommended) to mswann@cdc.gov, or
faxed to (202) 245–0554.
FOR FURTHER INFORMATION CONTACT:
Simon McNabb, Designated Federal
Official (DFO), ICSH, Office on Smoking
and Health, NCCDPHP, CDC, 395 E
Street SW, Room 9167, Washington, DC
20024, telephone (202) 245–0550;
GMcNabb@cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ICSH membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2020, or as
soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and
cannot be full-time employees of the
VerDate Sep<11>2014
16:49 Oct 03, 2019
Jkt 250001
U.S. Government. Candidates should
submit the following items:
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
D At least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself, or by the
person/organization recommending the
candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–21582 Filed 10–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–262 and
CMS–10662]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
SUMMARY:
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 3, 2019.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number __, Room C4–26–05,
7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ website address at
website address at https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.html.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–262 Contract Year 2021 Plan
Benefit Package (PBP) Software and
Formulary Submission
E:\FR\FM\04OCN1.SGM
04OCN1
]]>Agencies
[Federal Register Volume 84, Number 193 (Friday, October 4, 2019)]
[Notices]
[Pages 53155-53156]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21582]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Interagency
Committee on Smoking and Health (ICSH)
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
seeking nominations for membership on the ICSH. The ICSH consists of 5
experts in fields that represent private entities involved in informing
the public about the health effects of smoking. Nominations are being
sought for individuals who have expertise and qualifications necessary
to contribute to the accomplishments of the committee's objectives.
Nominees will be selected based on expertise in the fields of the
health effects of smoking. Additionally, desirable qualifications
include: (1) Knowledge of emerging tobacco control policies and
experience in analyzing, evaluating, and interpreting Federal, State
and/or local health or regulatory policy; and/or (2) familiarity and
expertise in developing or contributing to the development of policies
and/or programs for reducing health disparities in tobacco use in the
United States; and/or (3) knowledge of the intersection of behavioral
health conditions (mental and/or substance use disorders) and tobacco
use/tobacco control. Federal employees will not be considered for
membership. Members may be invited
[[Page 53156]]
to serve for four-year terms. Selection of members is based on
candidates' qualifications to contribute to the accomplishment of ICSH
objectives https://www.cdc.gov/tobacco/about/icsh/index.htm.
DATES: Nominations for membership on the ICSH must be received no later
than October 31, 2019. Packages received after this time will not be
considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Monica Swann, Office on
Smoking and Health, National Center for Chronic Disease Prevention and
Health Promotion (NCCDPHP), CDC, 395 E Street SW, Room 9167,
Washington, DC 20024, emailed (recommended) to [email protected], or faxed
to (202) 245-0554.
FOR FURTHER INFORMATION CONTACT: Simon McNabb, Designated Federal
Official (DFO), ICSH, Office on Smoking and Health, NCCDPHP, CDC, 395 E
Street SW, Room 9167, Washington, DC 20024, telephone (202) 245-0550;
[email protected].
SUPPLEMENTARY INFORMATION: The U.S. Department of Health and Human
Services policy stipulates that committee membership be balanced in
terms of points of view represented, and the committee's function.
Appointments shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, gender identity, HIV
status, disability, and cultural, religious, or socioeconomic status.
Nominees must be U.S. citizens, and cannot be full-time employees of
the U.S. Government. Current participation on federal workgroups or
prior experience serving on a federal advisory committee does not
disqualify a candidate; however, HHS policy is to avoid excessive
individual service on advisory committees and multiple committee
memberships. Committee members are Special Government Employees,
requiring the filing of financial disclosure reports at the beginning
and annually during their terms. CDC reviews potential candidates for
ICSH membership each year, and provides a slate of nominees for
consideration to the Secretary of HHS for final selection. HHS notifies
selected candidates of their appointment near the start of the term in
July 2020, or as soon as the HHS selection process is completed. Note
that the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year.
Nominees must be U.S. citizens, and cannot be full-time employees
of the U.S. Government. Candidates should submit the following items:
[ssquf] Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
[ssquf] At least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself, or
by the person/organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-21582 Filed 10-3-19; 8:45 am]
BILLING CODE 4163-18-P
